| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | cefadroxil |
| Formulation | 250 mg/5 ml granules for oral suspension; 500 mg capsule |
| Reference number | 2341 |
| Indication | Treatment of following infections caused by cefadroxil-susceptible organisms, when an oral therapy is indicated: streptococcal pharyngitis and tonsillitis; uncomplicated urinary tract infections; or uncomplicated skin and soft tissue infections. Consideration should be given to official guidance on the appropriate use of antibacterial agents |
| Company | ALKALOID-INT d.o.o. |
| BNF chapter | Infections |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 14/11/2013 |